|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 31/506 | (2013.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61P 19/00 | (2018.01) |
| (11) | Number of the document | 3856187 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19778516.5 |
| Date of filing the European patent application | 2019-09-27 | |
| (97) | Date of publication of the European application | 2021-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/076241 |
| Date | 2019-09-27 |
| (87) | Number | WO 2020/065034 |
| Date | 2020-04-02 |
| (30) | Number | Date | Country code |
| 18306275 | 2018-09-28 | EP |
| (72) |
LEGEAI-MALLET, Laurence , FR
|
| (73) |
Institut National de la Santé et de la
Recherche Médicale (INSERM) ,
101 rue de Tolbiac, 75013 Paris,
FR
Université Paris Cité , 85 boulevard Saint-Germain, 75006 Paris, FR ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS , 55 boulevard Diderot, 75012 Paris 12, FR Fondation Imagine , 24, Boulevard du Montparnasse, 75015 Paris, FR |
| (54) | INFIGRATINIB FOR TREATMENT OF FGFR3-RELATED SKELETAL DISEASES DURING PREGNANCY |
| INFIGRATINIB FOR TREATMENT OF FGFR3-RELATED SKELETAL DISEASES DURING PREGNANCY |